Multiple myeloma: CAR T-cell therapy generates lasting remissions
In a major advance in the treatment of multiple myeloma, a CAR T-cell therapy has…
Browsing: CAR T cell therapy
Novel target: could improve safety of therapy for pancreatic cancer
Researchers from Queen Mary University of London, UK, have identified a protein that may represent…
A potent weapon against lymphomas
Researchers from the The Max Delbrück Center (MDC) for Molecular Medicine in the Helmholtz Association…
ASH 2020: CAR T-cell therapy found highly effective in patients with high-risk non-Hodgkin lymphoma
A CAR T-cell therapy known as axicabtagene ciloleucel (axi-cel) drove cancer cells to undetectable levels…
Study identifies characteristics of infused CAR-T cells associated with efficacy and toxicity in patients with large B-cell lymphoma
Researchers at The University of Texas MD Anderson Cancer Center, USA, have identified molecular and…
FDA grants Fast Track designation to Calibr’s ‘switchable’ CAR-T cell cancer therapy
The U.S. Food and Drug Administration has granted Fast Track designation to a novel “switchable”…
Excellent research results for CAR-T Cell therapy against Hodgkin lymphoma
CAR-T cell therapy, which attacks cancer cells using a person’s reprogrammed immune cells, has been…
Boosting the power of immunotherapy for more effective cancer treatment
Activating two different types of immune cells at the same time has been shown to…
A promising new treatment for recurrent paediatric brain cancer
Two paediatric brain cancers that are challenging to treat if they recur, medulloblastoma and ependymoma,…
CAR T-cell therapy for solid tumours may advance cancer treatments
Immunotherapy with genetically modified lymphocytes, such as CAR-T cells, is one of the most promising…